 CAMBRIDGE, Mass., Jan. 04, 2023 GLOBE NEWSWIRE -- Editas Medicine, Inc. Nasdaq: EDIT, a clinical stage genome editing company, today announced that the Companys President and CEO Gilmore ONeill, M.B., M.M.Sc., will present at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023, 4:30 p.m. PT 7:30 p.m. ET in San Francisco, CA. 